Qurate Retail, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2022

Schedule of number and weighted average GDFV of option granted


	Nine months ended
	September 30, 2022
	RSUs Granted (000's)	Weighted Average GDFV

Series A Qurate Retail common stock, subsidiary employees (1)	11,101	$	4.82
Series A Qurate Retail common stock, Qurate Retail employees and directors (2)	217	$	4.91
Series A Qurate Retail common stock, Qurate Retail President and CEO (3)	596	$	4.91
Series B Qurate Retail common stock, Qurate Retail Chairman of the Board (4)	327	$	4.95

(1)

Grants mainly vest equally over three years.

(2)

Grants mainly vest one year from the month of grant, subject to the satisfaction of certain performance objectives.

(3)

Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with the employment agreement of our President and Chief Executive Officer.

(4)

Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with our Chairman’s employment agreement.

Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors


		Weighted			Weighted
	Series A	Average		Series B	Average
	(000's)	GDFV		(000's)	GDFV
RSUs outstanding at January 1, 2022	12,905	$	9.38	—	$	—
Granted	11,914	$	4.83	327	$	4.95
Vested	(3,859)	$	10.02	—	$	—
Forfeited/Cancelled	(3,479)	$	7.54	—	$	—
RSUs outstanding at September 30, 2022	17,481	$	6.50	327	$	4.95

Common Class A

Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards



				Weighted		Aggregate
				average		intrinsic
	Series A			remaining		value
	(000's)	WAEP		life		(millions)
Options outstanding at January 1, 2022	42,110	$	9.23
Granted	—	$	—
Exercised	(392)	$	2.26
Forfeited/Cancelled	(4,705)	$	10.70
Options outstanding at September 30, 2022	37,013	$	9.12	2.8	years	$	—
Options exercisable at September 30, 2022	25,260	$	10.81	2.0	years	$	—

Common Class B

Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards



				Weighted		Aggregate
				average		intrinsic
	Series B			remaining		value
	(000's)	WAEP		life		(millions)
Options outstanding at January 1, 2022	2,221	$	12.25
Granted	—	$	—
Exercised	—	$	—
Forfeited/Cancelled	—	$	—
Options outstanding at September 30, 2022	2,221	$	12.25	1.0	year	$	—
Options exercisable at September 30, 2022	2,221	$	12.25	1.0	year	$	—